Allegra in France: prescription, pharmacy and pricing
Allegra (Fexofenadine) is available in France under the regulatory framework of ANSM (Agence nationale de sécurité du médicament et des produits de santé). This page summarises how the medication is prescribed and dispensed locally, what insurance or the public system cover, and which options exist for legally and safely accessing Allegra 30mg, 60mg, 120mg, 180mg.
- Regulator
- ANSM (Agence nationale de sécurité du médicament et des produits de santé)
- Currency
- EUR
- Active ingredients
- Fexofenadine
- Available dosages
- 30mg, 60mg, 120mg, 180mg
Prescription status in France
In France, prescription medications are tightly regulated under several lists (Liste I, Liste II, stupéfiants). Sécurité sociale covers most prescription costs at varying rates depending on the drug. Allegra contains the active ingredient Fexofenadine, in the Allergy and Antihistamines class, and its classification in France follows the standard rules of ANSM (Agence nationale de sécurité du médicament et des produits de santé).
Pharmacy dispensing
Pharmacies in France are independent owner-pharmacist businesses, marked by the iconic green cross. The pharmacist is a routine medical consultant for minor ailments and triage. The pharmacist is the most reliable local source of information on stock, authorised substitutions (generic vs brand) and specific precautions for Allegra at the available strengths (30mg, 60mg, 120mg, 180mg).
Online and tele-prescribing access
Online pharmacy is permitted only via French ARS-authorised pharmacies physically located in France, primarily for non-prescription medication. Tele-consultation has expanded prescription access since 2020. Buying Allegra from unauthorised sellers or without local verification exposes the user to counterfeit medication and unmonitored use of Fexofenadine.
When Allegra is prescribed
Allegra is approved in adults and children for the treatment of seasonal allergic rhinitis and chronic idiopathic urticaria.
Pricing and availability in EUR
Retail pricing in France depends on the strength (30mg, 60mg, 120mg, 180mg), whether the original brand or an authorised generic is dispensed, and insurance or public-system coverage. The difference between brand and generic is usually the most meaningful economic lever for ongoing use. Comparing prices at two or more locally authorised pharmacies before first refill is recommended.
Frequently asked questions
Do I need a prescription for Allegra in France? ▾
In France, prescription medications are tightly regulated under several lists (Liste I, Liste II, stupéfiants). Sécurité sociale covers most prescription costs at varying rates depending on the drug. In practice, Allegra follows the status of its active ingredient Fexofenadine in the regulatory system of ANSM (Agence nationale de sécurité du médicament et des produits de santé).
Is generic Allegra available in France? ▾
Authorised generics of Fexofenadine are typically available in France at a lower cost than branded Allegra, with bioequivalence required by ANSM (Agence nationale de sécurité du médicament et des produits de santé). Substitution is handled by the pharmacist under local equivalence rules.
How much does Allegra cost in EUR? ▾
Prices in EUR vary by pharmacy and by strength (30mg, 60mg, 120mg, 180mg). Authorised generics of Fexofenadine are usually substantially cheaper than the brand and are the typical economic reference point for ongoing use in France.
Allegra in other countries
- the United StatesFDA (Food and Drug Administration)
- the United KingdomMHRA (Medicines and Healthcare products Regulatory Agency)
- SpainAEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
- MexicoCOFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios)
- ArgentinaANMAT (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica)
- GermanyBfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
- ItalyAIFA (Agenzia Italiana del Farmaco)
- BrazilANVISA (Agência Nacional de Vigilância Sanitária)
- CanadaHealth Canada
- South KoreaMFDS (Ministry of Food and Drug Safety)
- JapanPMDA (Pharmaceuticals and Medical Devices Agency)
- AustriaBASG (Federal Office for Safety in Health Care)
- SwitzerlandSwissmedic (Swiss Agency for Therapeutic Products)
- AustraliaTGA (Therapeutic Goods Administration)
- ColombiaInvima (National Food and Drug Surveillance Institute)
- ChileISP (Instituto de Salud Pública de Chile, Public Health Institute)
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.